FDA Orange Book · active-ingredient family
Cupric sulfate; manganese sulfate; selenious acid; zinc sulfate
Cupric sulfate; manganese sulfate; selenious acid; zinc sulfate is approved in 1 FDA application, with therapeutic-equivalence codes, listed patents, and marketing exclusivity from the FDA Orange Book.
Reference-listed drug:MULTRYS · NDA 209376
1
Brand (NDA)
0
Generics (ANDA)
5
Listed patents
0
Exclusivity periods
Brand (NDA) products · solution
| Product | Applicant | Application | TE | Approved | |
|---|---|---|---|---|---|
| MULTRYSRLD×3 | AM REGENT | NDA 209376 | — | Jun 30, 2021 |
Listed patents (5)
| Patent | Expires | In | Type |
|---|---|---|---|
| 12150957 | Jul 01, 2041 | in 15 yr 3 mo | U-3900 |
| 12150956 | Jul 01, 2041 | in 15 yr 3 mo | U-3900 |
| 11975022 | Jul 01, 2041 | in 15 yr 3 mo | U-3900 |
| 11786548 | Jul 01, 2041 | in 15 yr 3 mo | Product |
| 11998565 | Jul 01, 2041 | in 15 yr 3 mo | Product |
Cupric sulfate; manganese sulfate; selenious acid; zinc sulfate — frequently asked questions
Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

